Pharmaceutical Formulation Characterization Design
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 40
Special Issue Editors
Interests: solid dosage forms; tablets; quality by design; factorial design; artificial neural network
Special Issues, Collections and Topics in MDPI journals
Interests: buccal polymer films; mucoadhesion; proteins; quality by design; permeation enhancing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
This Special Issue in "Pharmaceuticals" is dedicated to reporting the latest scientific results in the field of "Formulation Characterization Design". At present, it is very important that, before the industrial production of pharmaceuticals, a given pharmaceutical form is extensively tested, which includes various structural tests, physical tests, and pharmacokinetic tests. It is necessary to find out whether there is any change in the active ingredient during pharmaceutical technological processes and whether this could influence the development of the effect. It is necessary to understand the relationships between different structural properties, the dissolution profile, and effect development in order to be able to design medicines more efficiently based on new knowledge. Appropriate planning is also very important, and this can be achieved primarily through risk analysis, the Quality by Design (QbD) approach, and the use of factorial experimental design (DoE). It is possible to determine the design space, which provides accurate information provides information about the Critical Process Parameter (CPP) values, within which the product with the quality target product profile (QTPP) will be suitable. Based on these, we can gain new knowledge and connections that are essential for efficient production later on. This Special Issue primarily publishes results related to the above-mentioned topic or some part of it, mainly in the field of solid dosage form formulation or intermediate products that can be used in them.
Dr. Tamás Sovány
Dr. Katalin Kristó
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- quality by design
- factorial design
- design space
- solid dosage forms
- risk assessment
- critical process parameters
- quality target product profile
